 Evelo also granted the underwriters a 30-day option, solely to cover over-allotments, if any, to purchase up to an additional 1,800,000 shares of its common stock. All of the shares in the offering are to be sold by Evelo. Morgan Stanley, Cowen and BMO Capital Markets are acting as joint book-running managers for the offering. 